Crown Equity Holdings Inc. (OTCBB:CRWE) is pleased to report its financial results for the nine month period ending September 30, 2010. Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009. "Our continued progress in operations including an operating profit of $7,251 during the last quarter shows a continued growth in our business," commented Kenneth Bosket, President and CEO of Crown Equity Holdings Inc. "Not only do our financial results show strong growth during this year but our continued investment in infrastructure will support our future growth," stated Bosket.
Crown Equity Holdings Inc. is extending its internet footprint internationally to include the following countries; Argentina, Brazil, Canada, China, France, Germany, Hong Kong, India, Indonesia, Italy, Japan, Korea, Malaysia, Mexico, New Zealand, Pakistan, Russia, Singapore, Spain, South Africa, Taiwan, United Arab Emirates and United Kingdom.
Crown Equity Holdings Inc. is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients. Crown Equity Holdings Inc. announced in June of this year its 1- 10 forward stock split.
Zalicus Inc. (NASDAQ:ZLCS) presented data yesterday on its discovery of novel synergistic drug combinations for the treatment of cancer at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Meeting in Berlin, Germany on November 18, 2010. In a poster presentation entitled “Identification of synergistic drugs using combination high-throughput screening (cHTS) and breadth of activity in diverse cancer cell networks,” Richard Rickles, Ph.D., Zalicus’s Director of Oncology Research demonstrated that systematic combination studies using the Zalicus combination high-throughput screening (cHTS) technology can reveal patterns of chemotherapeutic sensitivity and resistance to identify potentially responsive patient populations.
Zalicus Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases. Zalicus applies its selective ion-channel modulation platform and its combination high throughput screening capabilities to discover innovative therapeutics for itself and its collaborators in the areas of pain, inflammation, oncology and infectious disease.
Zanett, Inc. (NASDAQ:ZANE), a leading consulting firm specializing in serving Fortune 500 corporations and mid-market organizations in Health Care, Life Sciences, Manufacturing & Distribution, Retail, Gaming & Hospitality, and State & Local Government has announced its financial results for Q3 the nine months ended September 30, 2010.
Financial Highlights for the NINE months ended September 30, 2010 includes: 28% revenue growth to $12.7 million in Q3 2010, vs. $9.9 million in Q3 2010; 11% Growth for the nine months ended September 30, 2010 vs same period last year; $45+ million in total new contracts signed in first 9 months of 2010; GAAP operating income of $284k in first nine months of 2010; vs. GAAP operating loss of $652k in the same period 2009; Q3 GAAP net income of $95k, vs loss of $818k for same period 2009; and $150 million un-weighted sales pipeline as of September 30, 2010.
Zanett is a leading business process outsourcing (NYSE:BPO), IT enabled services (ITES), and information technology (NYSE:IT) consulting firm serving Fortune 500 corporations and mid-market organizations in Healthcare, Life Sciences, Manufacturing & Distribution, Retail, Gaming & Hospitality, and State & Local Government.
ZBB Energy Corporation (AMEX:ZBB), a leading developer of intelligent, renewable energy power platforms, provided additional information to investors as part of ZBB's on-going improvement in providing relevant information to its investors.
ZBB Energy Corporation provides distributed intelligent power management platforms that directly integrate multiple renewable and conventional onsite generation sources with rechargeable zinc bromide flow batteries and other storage technology.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.